The board of directors of Sinopharm Tech Holdings Limited announced that with effect from 1 August 2022: Mr. CHAN Ting ("Mr. CHAN") has resigned as the executive Director and chairperson of the Board of the Company in order to devote more time to his personal commitments. Madam CHEUNG Kwai Lan ("Madam CHEUNG") has resigned as the non-executive Director and honorary chairperson of the Company as she would like to devote more time to her family. The Board also announced that with effect from 1 August 2022: Mr. Lam Kit Sun ("Mr. LAM") has been appointed as an independent non-executive Director of the Company.

Mr. LAM Kit Sun, aged 45, is executive director, chief financial officer and company secretary of Universe Entertainment and Culture Group Company Limited, the securities of which are listed on the Main Board of The Stock Exchange of Hong Kong Limited since August 2013. He has over 20 years' experience in the field of financial reporting, financial management and audit experience in the PRC and Hong Kong. He graduated from The Hong Kong University of Science and Technology with a bachelor's degree in Business Administration in Accounting.

Mr. LAM is a fellow and practicing member of the Hong Kong Institute of Certified Public Accountants, a fellow member of the Association of Chartered Certified Accountants, an associate of The Hong Kong Chartered Governance Institute and anon-practicing member of the Chinese Institute of Certified Public Accountants. CHANGE IN COMPOSITION OF BOARD COMMITTEES: The Board further announces that with effect from 1 August 2022: Mr. CHAN has resigned as the chairperson and member of the nomination committee of the Company (the "Nomination Committee") and member of remuneration committee of the Company (the "Remuneration Committee"); Following the re-designation of Mr. CHAU from independent non-executive Director to executive Director of the Company, he has ceased to act as a member of the audit committee of the Company (the "Audit Committee"); and Mr. LAM, a new independent non-executive Director of the Company, has been appointed as a member of the Audit Committee and the Remuneration Committee and the chairperson and member of the Nomination Committee.